Katisha M. J. Brown
Senior Contracts Specialist | She/Her/Hers
Senior Contracts Specialist | She/Her/Hers
Areas of Focus
Overview
Katisha Brown has over a decade of experience in life sciences contract drafting, negotiation, and management, focusing on agreements for multicenter, global clinical trials.
Career & Education
- Senior Contract Manager, Kintai Therapeutics, Inc.
- Prepared, reviewed, and negotiated various agreements in support of R&D operations.
- Led and implemented company-wide legal immersion contracts training.
- Associate Contract Manager, Momenta Pharmaceuticals, Inc.
- Prepared, reviewed, and negotiated various agreements in support of R&D operations.
- Conducted Procurement and Contracts new hire trainings for employees, contractors, and consultants.
- Senior Contract Manager, Kintai Therapeutics, Inc.
- State University of New York, B.A., Sociology
- Molloy College, M.S., magna cum laude, Criminal Justice
- Massachusetts School of Law at Andover, J.D.
Representative Matters
- Supported multiple clinical trials of a bifunctional monoclonal antibody that targets B cells for multiple autoimmune diseases sponsored by an autoimmune disease focused biopharmaceutical company, including Phase 3 trials involving over 100 sites in North America, South America, Europe, and Asia.
- Supported Phase 1 through 3 multinational clinical trials sponsored by a clinical stage biopharmaceutical company in oncology involving sites in North America, Europe, South America, Asia, and Australia, including drafting, negotiating, and coordinating clinical trial agreements for a Phase 2 study involving 30 academic medical institutions in the United States.
- Supported Phase 1 and 2 clinical trials of an oral inhibitor sponsored by a clinical stage biopharmaceutical company involving approximately 90 subjects across 40 sites in North America and Europe.
- Drafted and negotiated agreements with service providers for clinical and preclinical studies of therapeutic and medical device products, including master services agreements valued at over $10 million with large, global research organizations.
